Chr. Hansen names new executive vice president and chief science officer

By Niamh Michail contact

- Last updated on GMT

© iStock
© iStock

Related tags: Microbiology

Thomas Schäfer, current vice president at Novozymes, has been appointed chief science officer and executive vice president at Danish firm Chr. Hansen.

Schäfer is expected to take up the new position in spring 2017.

By appointing a scientist to its executive board, the Danish company said it was placing innovation and science as a critical area for securing growth.

Its product portfolio includes cultures, enzymes, probiotics and natural colours.

dfgdf
Thomas Schaefer

Schäfer has more than 20 years’ experience in industrial microbiology, R&D and innovation under his belt, has published several papers and is the co-author of a number of patents.

CEO of Chr. Hansen Cees de Jong said Schäfer was a skilled and business-oriented technology leader with international experience.

“The overall goal of the R&D Microbial Platform is to secure a common and strong scientific backbone within industrial microbes that can sustain new innovations for the food cultures & enzymes and health & nutrition business units and support Chr. Hansen’s undisputed leadership in bacterial fermentation technology,” ​de Jong added.

Chr. Hansen counts over 2,800 employees across more than 30 countries worldwide.

For2015/2016 last financial year it reported revenue of €949 million.

Related topics: Suppliers, Functional foods

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars